In: Journal of Neural Transmission, 2011, vol. 118, no. 6, p. 945-955
|
In: Brain Topography, 2013, vol. 26, no. 4, p. 641-647
|
In: Acta Neuropathologica, 2004, vol. 108, no. 3, p. 207-212
|
In: Neuroscience, 2007, vol. 150, no. 3, p. 537-546
To determine whether Toxoplasma gondii infection could modify biological phenomena associated with brain ischemia, we investigated the effect of permanent middle cerebral artery occlusion (MCAO) on neuronal survival, inflammation and redox state in chronically infected mice. Infected animals showed a 40% to 50% decrease of infarct size compared with non-infected littermates 1, 4 and 14 days after...
|
In: Journal of Neural Transmission, 2010, vol. 117, no. 4, p. 489-498
|
In: The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2005, vol. 60, no. 5, p. 660-666
|
In: Schweizerische Ärztezeitung, 2010, vol. 91, no. 39, p. 1521-1225
|
In: Journal of Neurology, 2004, vol. 251, no. 6, p. 750-752
|
In: Brain, 2007, vol. 130, no. 11, p. 2830-2836
|
In: Journal of Neurochemistry, 2009///doi: 10.1111/j.1471-4159.2009.06098.x
Early studies showed that the administration of the anti-inflammatory cytokine interleukin-10 (IL10) protects against permanent middle cerebral artery occlusion (MCAO) in mice. In this study, transgenic mice expressing murine IL10 (IL10T) directed by the major histocompatibility complex Ea promoter were produced and used to explore the effect of chronically increased IL10 levels on MCAO-related...
|